SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Panduro A.
(Autor externo)

Obras con ISBN:1
Documentos en revistas:48
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:
1.- The Immune System and Viral Hepatitis (2017)
 
Documentos en revistas:
1.- Conjugated bilirubin reduces hepatitis E virus infectivity by modulating immunometabolic processes (2026)
 
2.- A global action agenda for turning the tide on fatty liver disease (2024)
 
3.- Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative (2024)
 
4.- Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject (2022)
 
5.- Clues to decipher the origin of severe acute hepatitis in children: a new enigma during the COVID-19 pandemic (2022)
 
6.- COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis (2021)
 
7.- Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease (2020)
 
8.- Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis (2020)
 
9.- Evidence for Increased Inflammatory Cytokine Profile in Hepatitis e Virus-Infected Obese Patients: Implications for Chronic Liver Disease (2020)
 
10.- A new stage in annals of hepatology (2018)
 
11.- Renovation of annals of hepatology?s scientific scope: Towards preventing rather than treating end-stage liver disease (2018)
 
12.- Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions (2018)
 
13.- Hepatitis e Virus Genotype 1 and Hepatitis A Virus Dual Infection in Pediatric Patients with a Low Socioeconomic Status from Mexico (2018)
 
14.- Conjugated Bilirubin Upregulates TIM-3 Expression on CD4+CD25+ T Cells: Anti-Inflammatory Implications for Hepatitis A Virus Infection (2018)
 
15.- Challenges in research and management of hepatitis e virus infection in Cuba, Mexico, and Uruguay (2018)
 
16.- Cytokine Signatures Discriminate Highly Frequent Acute Hepatitis a Virus and Hepatitis e Virus Coinfections from Monoinfections in Mexican Pediatric Patients (2017)
 
17.- High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status (2017)
 
18.- High prevalence of ITPA alleles associated with ribavirin-induced hemolytic anemia among Mexican population (2017)
 
19.- Conjugated Bilirubin Differentially Regulates CD4+T Effector Cells and T Regulatory Cell Function through Outside-In and Inside-Out Mechanisms: The Effects of HAV Cell Surface Receptor and Intracellular Signaling (2016)
 
20.- Association with spontaneous hepatitis C viral clearance and genetic differentiation of IL28B/IFNL4 haplotypes in populations from Mexico (2016)
 
21.- CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection (2016)
 
22.- Hepatitis e virus: An ancient hidden enemy in Latin America (2016)
 
23.- Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico (2015)
 
24.- Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients (2015)
 
25.- T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children (2015)
 
26.- Effect of the ADIPOQ Gene-11391G/A polymorphism is modulated by lifestyle factors in Mexican Subjects (2015)
 
27.- Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico (2015)
 
28.- Rethinking the immune properties of bilirubin in viral hepatitis: from bench to bedside (2015)
 
29.- Immunologic, metabolic and genetic factors in hepatitis C virus infection (2014)
 
30.- Hepatitis B virus infection in Latin America: A genomic medicine approach (2014)
 
31.- High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico (2014)
 
32.- Central adiposity and mortality after first-ever acute ischemic stroke (2013)
 
33.- Effect of Ala54Thr polymorphism of FABP2 on anthropometric and biochemical variables in response to a moderate-fat diet (2013)
 
34.- Distribution of HBV genotypes F and H in Mexico and Central America (2013)
 
35.- Cytokine expression profiles associated with distinct clinical courses in hepatitis a virus-infected children (2012)
 
36.- Prevalence of hepatitis A, B and C serological markers in children from western Mexico (2012)
 
37.- Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors: The PREMIER study [Paradoja de la obesidad y recuperación funcional en sobrevivientes a un primer infarto cerebral: Estudio PREMIER] (2010)
 
38.- PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage (2005)
 
39.- Prediction of the hepatitis C viremia using immunoassay data and clinical expertise. (2005)
 
40.- Differential effect of CCl4 on renal function in cirrhotic and non- cirrhotic rats (1999)
 
41.- Hepatic phenylalanine-hydroxylase and tyrosine-aminotransferase mRNA levels in rats adapted to diets with different concentrations of protein (1996)
 
42.- Regulation of apo B mRNA expression in liver and intestine during liver regeneration induced by CCl4 (1994)
 
43.- Congenital hypertrophy of the retinal pigment epithelium associated with familial adenomatous polyposis (1994)
 
44.- Differential regulation in the expression of hepatic genes in nephrotic and pair-fed rats (1993)
 
45.- Regulation of apolipoprotein A-1 and E gene expression in liver and intestine of nephrotic and pair-fed rats (1993)
 
46.- Angiotensin i-converting enzyme activity in rats with carbon tetrachloride-induced acute renal failure (1993)
 
47.- New strategies in the clinical evaluation of patients with colon cancer based on molecular studies [Nuevas estrategias en la evaluación clínica de pacientes con cáncer de colon con base en estudios moleculares.] (1993)
 
48.- Semiquantitative histologic evaluation of the liver in patients after liver transplantation (1992)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.